title: First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine.
authors.affiliation: Division of Infectious Diseases and Tropical Medicine, and German Center for Infection Research (DZIF), Medical Center of the University of Munich, LMU, Munich 80802, Germany. Electronic address: geldmacher@lrz.uni-muenchen.de.
authors.forename: Christof
authors.initials: C
authors.lastname: Geldmacher
authors.affiliation: South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine, University of Cape Town, Cape Town, South Africa.
authors.forename: Mark
authors.initials: M
authors.lastname: Hatherill
mesh_terms: D001500:BCG Vaccine; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D014376:Tuberculosis / Q000517:prevention & control; D032581:Tuberculosis Vaccines; D014613:Vaccines, Attenuated
chemical_list: D001500:BCG Vaccine; D032581:Tuberculosis Vaccines; D014613:Vaccines, Attenuated